Long-term survival of older breast cancer patients: Population-based estimates over three decades

Breast Cancer Research and Treatment

Volumn 134, Issue 2, 2012, Pages 853-857

  Kanapuru, Bindu ^a,b   Ershler, William B ^b   Hesdorffer, Charles ^a   Jemal, Ahmedin ^c   Yates, Jerome W ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Institute for Advanced Studies on Aging   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

Aging; Breast cancer; Seer; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOCIAL SUPPORT; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; POPULATION; SEER PROGRAM; SURVIVORS; UNITED STATES;

EID: 84868197773     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2115-4     Document Type: Article

References (42)

1. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a metaanalysis. Cancer Epidemiol Biomarkers Prev 15(6):1159-1169. doi:10.1158/1055-9965. EPI-06-0034
2. Aiello EJ, Buist DS, White E, Porter PL (2005) Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 14(3):662-668. doi:10.1158/1055-9965. EPI-04-0327
3. Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Vachon CM (2008) Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(4):872-879. doi:10.1158/1055-9965. EPI-07-0559
4. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G (2009) Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18(2):479-485. doi:10.1158/1055-9965. EPI-08-0805
5. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E (2009) Breast density and outcome of mammography screening: a cohort study. Br J Cancer 100(7):1205-1208. doi:10.1038/sj.bjc.66 04989
6. Roubidoux MA, Bailey JE, Wray LA, Helvie MA (2004) Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology 230(1):42-48. doi:10.1148/radiol. 2301020589
7. Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N (2000) Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol 10(1):157-161
8. Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, Valero V, Hortobagyi G, Atchley D, Arun B (2008) Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 111(3):405-410. doi:10.1007/s10549-007-9810-6
9. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 13(12):2090-2095
10. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103(15):1179-1189. doi:10.1093/jnci/djr225
11. Ding J, Warren R, Girling A, Thompson D, Easton D (2010) Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 16(3):279-289. doi:10.1111/j.1524-4741.2010.00907.x
12. Conroy SM, Pagano I, Kolonel LN, Maskarinec G (2011) Mammographic density and hormone receptor expression in breast cancer: the multiethnic cohort study. Cancer Epidemiol 35(5):448-452. doi:10.1016/j.canep. 2010.11.011
13. Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters:25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19(5):1219-1228. doi:10.1158/1055-9965. EPI-09-1028
14. Heusinger K, Jud SM, Haberle L, Hack C, Adamietz BR, Meier-Meitinger M, Lux MP, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA (2012) Association of mammographic density with hormone receptors in invasive breast cancers-results from a case-only study. Int J Cancer. doi:10.1002/ijc.27515
15. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI (2012) Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. doi:10.1016/j. annepidem.2012.02.002
16. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227-236. doi:10.1056/ NEJMoa062790
17. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276(1):33-38
18. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval-and screendetected cancers. J Natl Cancer Inst 92(13):1081-1087
19. Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2006) Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 12(4):186-193. doi:10.1258/136218006 779160436
20. Bentzon N, During M, Rasmussen BB, Mouridsen H, Kroman N (2008) Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 122(5):1089-1094. doi:10.1002/ijc.22892
21. Harrison DA, Duffy SW, Sala E, Warren RM, Couto E, Day NE (2002) Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. J Clin Epidemiol 55(11):1113-1118
22. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A (1996) Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 66(4):413-419. doi:10.1002/(SICI) 1097-0215 (19960516) 66:4\413:AID-IJC1[3.0. CO;2-Z
23. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6):217. doi:10.1186/bcr1829
24. Rosenberg LU, Granath F, Dickman PW, Einarsdottir K, Wedren S, Persson I, Hall P (2008) Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study. Breast Cancer Res 10(5):R78. doi:10.1186/bcr2145
25. Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW (2006) Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res 8(1):R11. doi:10.1186/bcr1378
26. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO (1998) Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 76(1):29-34
27. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10(3):243-248
28. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14):3744-3748
29. Tamimi RM, Hankinson SE, Colditz GA, Byrne C (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2641-2647. doi:10.1158/1055-9965. EPI-05-0558
30. Livshits G, Malkin I, Williams FM, Hart DJ, Hakim A, Spector TD (2011) Longitudinal study of variation in body mass index in middle-aged UK females. Age (Dordr). doi:10.1007/s11357-011-9299-0
31. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629-1638
32. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171-176
33. Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I (1999) Breast-cancer risk following long-term oestrogen-and oestrogen-progestin- replacement therapy. Int J Cancer 81(3):339-344
34. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
35. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670-675
36. Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13(6):223. doi:10.1186/bcr2942
37. Akaike H (1974) New look at statistical-model identification. IEEE Trans Autom Control 19(6):716-723
38. Weinberg R (2006) The biology of cancer, 1st edn. Garland Science, New York
39. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, Carter C, Hoover R (2001) Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12(2):103-110
40. Brekelmans CT, Peeters PH, Faber JA, Deurenberg JJ, Collette HJ (1994) The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 30(3):223-232
41. Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355(9200):270-274. doi:10.1016/S0140-6736 (99) 07319-5
42. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502. doi:10.1001/jama.295.21.2492